A Phase II Study of Docetaxel Before Medical Castration With Degarelix in Patients With Newly Diagnosed Metastatic Prostatic Adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 26 Oct 2018
At a glance
- Drugs Degarelix (Primary) ; Docetaxel (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Mar 2017 Status changed from not yet recruiting to recruiting.
- 07 Mar 2017 New trial record